164 related articles for article (PubMed ID: 33340567)
1. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.
Ueda K; Taylor LS
J Control Release; 2021 Feb; 330():229-243. PubMed ID: 33340567
[TBL] [Abstract][Full Text] [Related]
2. Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.
Ueda K; Higashi K; Moribe K; Taylor LS
Mol Pharm; 2022 Jan; 19(1):100-114. PubMed ID: 34702040
[TBL] [Abstract][Full Text] [Related]
3. Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.
Ueda K; Taylor LS
Mol Pharm; 2020 Apr; 17(4):1352-1362. PubMed ID: 32097023
[TBL] [Abstract][Full Text] [Related]
4. Unusual Correlation between the Apparent Amorphous Solubility of a Drug and Solubilizer Concentration Revealed by NMR Analysis.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2022 Sep; 19(9):3336-3349. PubMed ID: 35924819
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 2: Effects of Solubilizer.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2023 Apr; 20(4):1872-1883. PubMed ID: 36939568
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mobility Suppression of Ibuprofen-Rich Amorphous Nanodroplets by HPMC Revealed by NMR Relaxometry and Its Significance with Respect to Crystallization Inhibition.
Ueda K; Yamamoto N; Higashi K; Moribe K
Mol Pharm; 2019 Dec; 16(12):4968-4977. PubMed ID: 31661287
[TBL] [Abstract][Full Text] [Related]
7. Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2017 Jul; 14(7):2314-2322. PubMed ID: 28558250
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947
[TBL] [Abstract][Full Text] [Related]
9. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug Chiralities.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2023 Apr; 20(4):1861-1871. PubMed ID: 36939575
[TBL] [Abstract][Full Text] [Related]
11. Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy.
Ueda K; Moseson DE; Pathak V; Taylor LS
Mol Pharm; 2021 Mar; 18(3):1344-1355. PubMed ID: 33595322
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
[TBL] [Abstract][Full Text] [Related]
13. Impact of Surfactants on Polymer Maintained Nifedipine Supersaturation in Aqueous Solution.
Wang S; Liu C; Chen H; Zhu AD; Qian F
Pharm Res; 2020 May; 37(6):113. PubMed ID: 32476051
[TBL] [Abstract][Full Text] [Related]
14. Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersion.
Zhao Z; Higashi K; Ueda K; Moribe K
Int J Pharm; 2021 Sep; 607():120984. PubMed ID: 34389423
[TBL] [Abstract][Full Text] [Related]
15. Phase separation in surfactant-containing amorphous solid dispersions: Orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition.
Yang R; Zhang GGZ; Kjoller K; Dillon E; Purohit HS; Taylor LS
Int J Pharm; 2022 May; 619():121708. PubMed ID: 35364219
[TBL] [Abstract][Full Text] [Related]
16. Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
Indulkar AS; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
Pharm Res; 2017 Jun; 34(6):1276-1295. PubMed ID: 28352994
[TBL] [Abstract][Full Text] [Related]
17. Impact of Colloidal Drug-Rich Droplet Size and Amorphous Solubility on Drug Membrane Permeability: A Comprehensive Analysis.
Ueda K; Takemoto S; Higashi K; Moribe K
J Pharm Sci; 2024 Jun; ():. PubMed ID: 38942292
[TBL] [Abstract][Full Text] [Related]
18. Impact of Hypromellose Acetate Succinate Grade on Drug Amorphous Solubility and In Vitro Membrane Transport.
Ueda K; Hate SS; Taylor LS
J Pharm Sci; 2020 Aug; 109(8):2464-2473. PubMed ID: 32353454
[TBL] [Abstract][Full Text] [Related]
19. Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal.
Zhu W; Romanski FS; Meng X; Mitra S; Tomassone MS
Eur J Pharm Sci; 2011 Apr; 42(5):452-61. PubMed ID: 21291999
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid-Liquid Phase Separation.
Yoshikawa E; Ueda K; Hakata R; Higashi K; Moribe K
Mol Pharm; 2024 Apr; 21(4):1745-1755. PubMed ID: 38501717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
